Literature DB >> 17444494

Jumping translocations.

Roland Berger1, Olivier A Bernard.   

Abstract

Jumping translocations (JT) are uncommon constitutional or acquired chromosome rearrangements involving one donor and several recipient chromosomes. They occur in various pathologic conditions and the mechanism of their formation remains elusive. A review of the literature showed that the major localizations of the breakpoints of JTs in human samples are nonrandomly located in pericentromeric and telomeric regions of chromosomes. Interestingly, comparison of the localization of the chromosomal breakpoints and of presence of interstitial DNA repeats showed differences between constitutional and acquired JTs suggesting differences in the mechanisms for the genesis of JTs and their consequences.

Entities:  

Mesh:

Year:  2007        PMID: 17444494     DOI: 10.1002/gcc.20456

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Jumping translocations, a novel finding in chronic lymphocytic leukaemia.

Authors:  Cecelia R Miller; Deborah Stephens; Amy S Ruppert; Frederick Racke; Andrew McFaddin; Heather Breidenbach; Huey-Jen Lin; Kathy Waller; Tammy Bannerman; Jeffrey A Jones; Jennifer A Woyach; Leslie A Andritsos; Kami Maddocks; Weiqiang Zhao; Gerard Lozanski; Joseph M Flynn; Michael Grever; John C Byrd; Nyla A Heerema
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 6.998

3.  Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.

Authors:  David Sanford; Courtney D DiNardo; Guilin Tang; Jorge E Cortes; Srdan Verstovsek; Elias Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

4.  Jumping translocations in myelodysplastic syndromes.

Authors:  Cecilia C S Yeung; H Joachim Deeg; Colin Pritchard; David Wu; Min Fang
Journal:  Cancer Genet       Date:  2016-08-08

5.  Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3.

Authors:  Peter McGrattan; Amy Logan; Mervyn Humphreys; Margaret Bowers
Journal:  Med Oncol       Date:  2009-07-22       Impact factor: 3.064

6.  Jumping translocations of 1q in donor cell-derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature.

Authors:  Toshinori Kondo; Taizo Tasaka; Risa Shimizu; Kiyohito Hayashi; Seiko Yamada; Hirofumi Fukuda; Tadashi Hirose; Asako Takeuchi; Fuminori Sano; Hirotoshi Tokunaga; Yoshiko Matsuhashi; Hideho Wada
Journal:  Mol Clin Oncol       Date:  2020-02-06

7.  Cytogenetic characterization of HB2 epithelial cells from the human breast.

Authors:  Fabio Caradonna; Claudio Luparello
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-27       Impact factor: 2.416

8.  Unbalanced jumping translocation involving 3q in myeloproliferative disease.

Authors:  Peter McGrattan; Mervyn Humphreys; Donald Hull
Journal:  Med Oncol       Date:  2008-05-29       Impact factor: 3.064

9.  Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63.

Authors:  Narasimharao V Marella; Michael J Zeitz; Kishore S Malyavantham; Artem Pliss; Sei-ichi Matsui; Sandra Goetze; Juergen Bode; Ivan Raska; Ronald Berezney
Journal:  Chromosome Res       Date:  2008-11-15       Impact factor: 5.239

10.  A robust framework for detecting structural variations in a genome.

Authors:  Seunghak Lee; Elango Cheran; Michael Brudno
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.